1. | | Recruiting | The "Reach For Health" Program: Delaying Sexual Activity in Children Conditions: Sex Behavior; Child Behavior |
2. | | Recruiting | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm |
3. | | Recruiting | 131MIBG to Treat Malignant Pheochromocytoma Condition: Pheochromocytoma |
4. | | Recruiting | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
5. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors Condition: Cancer |
6. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas Conditions: adult solid tumor; Leukemia; Lymphoma |
7. | | Recruiting | 17-DMAG to Treat Patients with Solid Tumors or Lymphomas Conditions: Neoplasms; Lymphoma |
8. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor Condition: unspecified adult solid tumor, protocol specific |
9. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma Condition: Cancer |
10. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma |
11. | | Not yet recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
12. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Conditions: adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ... |
13. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Stage III or Stage IV Melanoma Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma |
14. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer Conditions: stage I renal cell cancer; von Hippel-Lindau Syndrome |
15. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma |
16. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia Conditions: unspecified childhood solid tumor, protocol specific; recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; ... |
17. | | Recruiting | 17AAG to Treat Kidney Tumors in von Hippel-Lindau Disease |
18. | | Recruiting | 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors Conditions: refractory plasma cell neoplasm; stage III multiple myeloma; unspecified adult solid tumor, protocol specific |
19. | | Not yet recruiting | 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
20. | | Recruiting | 3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
21. | | Recruiting | 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer |
22. | | Recruiting | 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer Condition: Non-small cell lung cancer |
23. | | Recruiting | 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ... |
24. | | Recruiting | 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Biliary Duct or Gallbladder Cancer Conditions: unresectable extrahepatic bile duct cancer; recurrent gallbladder cancer; unresectable gallbladder cancer; recurrent extrahepatic bile duct cancer; ... |
25. | | Recruiting | 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia |
26. | | Recruiting | 3-AP as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma (Cancer) of the Pancreas Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ... |
27. | | Recruiting | 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome Conditions: acute leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; chronic leukemia; ... |
28. | | Recruiting | 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer |
29. | | Recruiting | 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction Conditions: recurrent esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus |
30. | | Recruiting | 3-D Laser Imaging to Analyze Neck Movement Conditions: Neck Pain; Manipulation, Spinal |
31. | | Recruiting | 3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection Conditions: stage I breast cancer; stage II breast cancer |
32. | | Recruiting | 4-Day-A-Week Treatment Plan for HIV Infected Adolescents Condition: HIV Infections |
33. | | Recruiting | 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Conditions: recurrent adult acute lymphoblastic leukemia; T-cell adult acute lymphoblastic leukemia; recurrent adult lymphoblastic lymphoma |
34. | | Recruiting | ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer Conditions: stage IV non-small cell lung cancer; recurrent non-small cell lung cancer |
35. | | Recruiting | ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma Conditions: Recurrent Melanoma; stage III melanoma; Stage IV Melanoma |
36. | | Recruiting | ABI-007, Carboplatin, and Trastuzumab in Treating Patients With HER2/neu-Overexpressing Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer |
37. | | Recruiting | Absorption and Distribution of Glucosamine and Chondroitin Condition: Osteoarthritis |
38. | | Recruiting | ABT-751 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That is Refractory to Taxane Therapy Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
39. | | Recruiting | ABT-751 in Treating Young Patients With Refractory Solid Tumors Condition: childhood cancer |
40. | | Recruiting | ABX-EGF in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Chemotherapy Conditions: adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; ... |
41. | | Recruiting | Acceptance-Based Treatment for Generalized Anxiety Disorder Condition: Anxiety Disorders |
42. | | Recruiting | ACE Inhibition and Novel Cardiovascular Risk Factors Conditions: Cardiovascular Diseases; Heart Diseases; Hypertension |
43. | | Recruiting | Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy Conditions: HIV Infections; Peripheral Nervous System Diseases |
44. | | Recruiting | ACP-103 to Treat Parkinson's Disease |
45. | | Recruiting | The Acquisition of Blood and Skin Samples from Normal Volunteers to Support Research Activities on Dermatologic Diseases Conditions: Healthy; Skin Disease |
46. | | Recruiting | Action to Control Cardiovascular Risk in Diabetes (ACCORD) Conditions: Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus, non-insulin dependent; Diabetes Mellitus; ... |
47. | | Recruiting | Activating Effects of Sleep Deprivation on Synchronized MEG-EEG Recordings of Epilepsy Patients with Non-Diagnostic EEG Condition: Epilepsy |
48. | | Recruiting | Activation and Function of Eosinophils in Conditions with Blood or Tissue Eosinophilia Conditions: Asthma; Eosinophilia; Helminthiasis; Hypersensitivity; Parasitic Disease |
49. | | Recruiting | Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA Condition: Renal Cell Carcinoma |
50. | | Recruiting | Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer Conditions: Breast Cancer; nausea and vomiting |